AbbVie’s blockbuster drug Humira finally loses its 20-year, $200 billion monopoly
(Leslie Walker and Dan Gorenstein for NPR) After 20 years and $200 billion in revenue, Humira — an injectable treatment
Read More(Leslie Walker and Dan Gorenstein for NPR) After 20 years and $200 billion in revenue, Humira — an injectable treatment
Read More(By Jakob Emerson for Becker’s Hospital Review ) A bipartisan group of senators are once again pushing for new regulations
Read More(By Fred Schulte for Kaiser Health News) Medicare Advantage plans for seniors dodged a major financial bullet Monday as government
Read More(Source - www.cms.gov) CMS has a number of resources available to help people with Medicare understand the reduced drug costs
Read More(By Jakob Emerson for Becker’s Hospital Review ) Diabetic patients that were forced to enroll in a high-deductible health plan
Read More(By Fred Schulte for Kaiser Health News) Today, KHN has released details of 90 previously secret government audits that reveal
Read MoreMedicare pays Medicare Advantage plans a set amount for each enrollee. In 2022, 49 percent of eligible Medicare beneficiaries were
Read More(By Juliette Cubanski and Tricia Neuman for the Kaiser Family Foundation Published: Jan 19, 2023) Medicare, the federal health insurance
Read More(Source -www.cms.gov) The U.S. Department of Health and Human Services (HHS) announced key dates for the first year of the
Read More(By Jared Ortaliza, Justin Lo, Gary Claxton, Krutika Amin, and Cynthia Cox Follow for Kaiser Family Foundation published on Jan
Read More